Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not

Highlights • Nearly half of all patients with advanced NSCLC did not receive any systemic therapy. • The most common reason for lack of treatment was due to a poor performance status. • Untreated patients had poorer prognostic features and shorter overall survival. • We must allocate research equita...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2016-07, Vol.97, p.15-21
Hauptverfasser:	Brule, Stephanie Y, Albaimani, Khalid, Jonker, Hannah, Zhang, Tinghua, Nicholas, Garth, Goss, Glenwood, Laurie, Scott A, Wheatley-Price, Paul
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Advocacy Aged Aged, 80 and over Best supportive care Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - therapy Chemotherapy Disease-Free Survival Female Health Status Disparities Hematology, Oncology and Palliative Medicine Humans Karnofsky Performance Status Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - therapy Male Middle Aged Non-small cell lung cancer Palliative Palliative Care - methods Palliative systemic therapy Pulmonary/Respiratory Quality of Life Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Nearly half of all patients with advanced NSCLC did not receive any systemic therapy. • The most common reason for lack of treatment was due to a poor performance status. • Untreated patients had poorer prognostic features and shorter overall survival. • We must allocate research equitably to improve outcomes in the untreated and unfit
ISSN:	0169-5002 1872-8332
DOI:	10.1016/j.lungcan.2016.04.007